₹23.00
as total savings
(including Shipping)
₹23
will be deposited into your Dermawallet as cashback after delivery
The Derma Co 2% Niacinamide Hydrating BB cream 01-IVORY Patch Test Certificate
Dermatologically Tested & Certified
Patch Test Certificate: The Derma Co 2% Niacinamide Hydrating BB cream 01-IVORY - Dermatologically Safe & Non-Irritant
The Derma Co 2% Niacinamide Hydrating BB cream 01-IVORY was evaluated for Primary Skin Irritation on human subjects at Cliantha Research (Selvius Research), an independent clinical research facility, under the direct supervision of a consultant dermatologist. The study (Protocol No. C3B02650, dated 11 August 2023) certified the product as Dermatologically Safe for use and Non-Irritant. This page publishes the complete certificate, the study details, and the standards followed, so you can see the safety documentation behind the product before you buy it.
What Is a Patch Test Certificate?
A patch test is a dermatological safety assessment in which a product is applied to the skin of human volunteers under controlled clinical conditions and observed for signs of irritation or allergic reaction. The study is conducted by an independent laboratory, after Ethics Committee approval, under the direct supervision of a qualified dermatologist.
A patch test certificate is the formal document issued by the testing laboratory stating the outcome of that study. It tells you three things: who tested the product, how it was tested, and what the result was. For The Derma Co 2% Niacinamide Hydrating BB cream 01-IVORY, all three are published in full on this page.
Certificate Result: Dermatologically Safe & Non-Irritant
Dermatologically Safe
Certified for use after Primary Skin Irritation Testing on human subjects
Non-Irritant
No skin irritation observed in the clinical study
BIS-Guideline Study
Conducted per IS 4011 (2018) with Ethics Committee approval
The Derma Co 2% Niacinamide Hydrating BB cream 01-IVORY, manufactured by Honasa Consumer Pvt. Ltd., underwent Primary Skin Irritation Testing on human subjects at Cliantha Research | Selvius Research (Clinical Research and Analytics). The study was carried out upon Ethics Committee approval under the direct supervision of Dr. Bhagirath Patel, M.D., DVL, Consultant Dermatologist, with Dr. Parth Joshi as Principal Investigator.
Based on the study - Protocol No. C3B02650, Sub Study No. C3B02650-HON-K, dated 11 August 2023 - the product was found to be Dermatologically Safe for use and Non-Irritant. The clinical study followed Bureau of Indian Standards (BIS) guidelines, including IS 4011 (2018) PCD 19: Cosmetics (third revision) and IS 13424:2001.
Key Certificate Details
| Attribute | Detail |
|---|---|
| Product Tested | The Derma Co 2% Niacinamide Hydrating BB cream 01-IVORY |
| Company | Honasa Consumer Pvt. Ltd. |
| Testing Laboratory | Cliantha Research | Selvius Research (Clinical Research and Analytics) |
| Test Type | Primary Skin Irritation Testing on human subjects |
| Ethics Approval | Conducted upon Ethics Committee approval |
| Study Protocol No. | C3B02650 |
| Sub Study Number | C3B02650-HON-K |
| Certificate Date | 11 August 2023 |
| Result | Dermatologically Safe for use; Non-Irritant |
| Principal Investigator | Dr. Parth Joshi |
| Consultant Dermatologist | Dr. Bhagirath Patel, M.D., DVL |
| Standards Followed | BIS IS 4011 (2018) PCD 19: Cosmetics (third revision); CHD 25: Soaps and Other Surface Active Agents; IS 13424:2001 |
The Certified Product
Dermatologically Tested
The Derma Co 2% Niacinamide Hydrating BB cream 01-IVORY
Dermatologically Tested: Certified Dermatologically Safe for use; Non-Irritant.
Certified Dermatologically Safe for use; Non-Irritant in an independent clinical study - see the full ingredient list, offers and reviews on the product page.
Shop NowAbout The Derma Co 2% Niacinamide Hydrating BB cream 01-IVORY
The Derma Co 2% Niacinamide Hydrating BB cream 01-IVORY is part of The Derma Co's dermatologically tested product line. Every safety claim on this page is backed by the certificate published above - including the study protocol number, the testing standards, and the supervising dermatologist's certification. Key ingredients include Niacinamide. Learn how this product category helps with hyperpigmentation and dark spots.
Independently Tested
Evaluated on human subjects at an independent laboratory after Ethics Committee approval - not self-certified.
Dermatologist Supervised
The clinical study was conducted under the direct supervision of a qualified consultant dermatologist.
BIS-Guideline Study
Testing followed Bureau of Indian Standards protocols, including IS 4011 (2018) for cosmetics.
Certificate Published in Full
The original certificate image and complete transcription are on this page - nothing summarized away.
View the Original Certificate
Patch Test Certificate issued by Cliantha Research | Selvius Research - Study Protocol No. C3B02650, dated 11 August 2023.
Full Certificate Text
Read the complete certificate transcription
x @
6 SISISISISISSS ISIS ISIS SSSI IIIS SSS IS IIIS IIIS SII IIIS II III IIIS IIIS II II IIIS
SLLIILIIIIIIIII IS
cliantha | S&ivius
research CLINICAL RESEARCH AND ANALYTICS
Study Protocol No.: C3B02650
Sub Study Number: C3B02650-HON-K Date: 11 Aug 23
This is to Certify that
TDC 2% Niacinamide Hydrating BB Cream 01 -Ilvory of Honasa Consumer
Pvt. Ltd. was evaluated upon Ethics Committee Approval for Primary Skin
Irritation Testing on human subjects and was found to be
. Dermatologically Safe for use
Non-lrritant
Dr. Bhagirath Patel Dr. Parth Joshi
M.D. DVL (Consultant Dermatologist) Principal Investigator
Note: The Clinical study was conducted as per BIS (Bureau of Indian Standards) guidelines [IS 4011 (2018) PCD 19: Cosmetics) guidelines, third revision and/or
CHD 25: Soaps and Other Surface Active Agents Sectional Committee [first revision and IS 13424:2001 Safety evaluation of bathing bars and toilet soaps], under
the direct supervision of Dermatologist and Principal Investigator.
ee 4 x@ SILILIIILISIS IIIS IIIS SII IIIS III IIIS III IIIS II III IIIS IIIS IIIS
() LLL SILIIIIIILIIIII IIIS ISIS III ELISE IIIS
) ey
yx)
ZO)
Important Points to Know Before Use
1. Even gentle formulations can trigger existing allergies - a personal patch test is recommended before first use.
2. In case of any rashes or allergy, discontinue use and consult a specialist.
3. For external use only. Store in a cool and dry place, away from direct sunlight.
Frequently Asked Questions
A: Yes. It underwent Primary Skin Irritation Testing on human subjects (Study Protocol No. C3B02650) and was certified Dermatologically Safe for use; Non-Irritant.
A: It is the formal document issued by the testing laboratory stating who tested the product, how it was tested, and the outcome. The original image and full transcription are published on this page.
A: The study was conducted under the direct supervision of Dr. Bhagirath Patel, M.D., DVL (Consultant Dermatologist), with Dr. Parth Joshi as Principal Investigator, after Ethics Committee approval.
A: The clinical study followed Bureau of Indian Standards (BIS) guidelines, including IS 4011 (2018) PCD 19 for cosmetics, and was carried out after Ethics Committee approval.
A: Yes. Certificate results reflect testing on a sample group under clinical conditions, and individual skin can react differently. Apply a small amount on your inner arm, wait 24 hours, and check for any reaction before regular use.
Shop The Derma Co 2% Niacinamide Hydrating BB cream 01-IVORY
You've seen the certificate - clinically evaluated, dermatologist-supervised, and certified Non-Irritant. See the full ingredient list, offers, and reviews on the product page, or explore the complete Niacinamide range.